1. Home
  2. MIST vs PETS Comparison

MIST vs PETS Comparison

Compare MIST & PETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIST
  • PETS
  • Stock Information
  • Founded
  • MIST 2003
  • PETS 1996
  • Country
  • MIST Canada
  • PETS United States
  • Employees
  • MIST N/A
  • PETS N/A
  • Industry
  • MIST Biotechnology: Pharmaceutical Preparations
  • PETS Retail-Drug Stores and Proprietary Stores
  • Sector
  • MIST Health Care
  • PETS Consumer Staples
  • Exchange
  • MIST Nasdaq
  • PETS Nasdaq
  • Market Cap
  • MIST 81.5M
  • PETS 82.0M
  • IPO Year
  • MIST N/A
  • PETS N/A
  • Fundamental
  • Price
  • MIST $1.43
  • PETS $4.07
  • Analyst Decision
  • MIST Strong Buy
  • PETS Sell
  • Analyst Count
  • MIST 3
  • PETS 2
  • Target Price
  • MIST $13.00
  • PETS $3.50
  • AVG Volume (30 Days)
  • MIST 177.8K
  • PETS 182.6K
  • Earning Date
  • MIST 11-11-2024
  • PETS 11-06-2024
  • Dividend Yield
  • MIST N/A
  • PETS 29.41%
  • EPS Growth
  • MIST N/A
  • PETS N/A
  • EPS
  • MIST N/A
  • PETS N/A
  • Revenue
  • MIST N/A
  • PETS $270,772,000.00
  • Revenue This Year
  • MIST N/A
  • PETS N/A
  • Revenue Next Year
  • MIST N/A
  • PETS $3.27
  • P/E Ratio
  • MIST N/A
  • PETS N/A
  • Revenue Growth
  • MIST N/A
  • PETS 2.26
  • 52 Week Low
  • MIST $1.12
  • PETS $2.90
  • 52 Week High
  • MIST $3.52
  • PETS $8.27
  • Technical
  • Relative Strength Index (RSI)
  • MIST 42.50
  • PETS 56.76
  • Support Level
  • MIST $1.41
  • PETS $3.78
  • Resistance Level
  • MIST $1.53
  • PETS $4.17
  • Average True Range (ATR)
  • MIST 0.07
  • PETS 0.18
  • MACD
  • MIST -0.01
  • PETS -0.01
  • Stochastic Oscillator
  • MIST 26.96
  • PETS 62.22

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About PETS PetMed Express Inc.

PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.

Share on Social Networks: